“Newborn screening is not simply buying a kit or a machine; it’s a whole approach of analysis and interpretation. Now, it’s time to convince the authorities to move forward”, says Dr. Issam Khneisser, NBS pioneer in the Middle East and North Africa (MENA) region.
We would like to recognize the Hospital Nacional Docente Madre Niño San Bartolome as the first newborn screening laboratory in Lima, Peru to join laboratories world-wide using AutoDELFIA® analyzers to screen for TSH and 17 OHP. This laboratory also expects to be the first lab in Peru to meet the government mandate to screen all newborns for Cystic Fibrosis using the IRT assay. Congratulations to Dr. Bindels and her team for making this happen.
The NBS Program in the Philippines started out as a pilot project involving 24 hospitals in the country’s capital region. It took some time for the newborn screening program to be successfully integrated into the national health program through the Philippine Newborn Screening Act of 2004. Almost two decades after the pilot project, the program was deemed ready for the expansion from screening for six disorders to screening for more than 20 disorders. The presentation from Dr. Melanie presents the challenges of implementing an expanded newborn screening program in a developing country like the Philippines and the conditions identified in the first phases of offering the service.